Method of Ameliorating or Abrogating the Effects of a Neurodegenerative Disorder, Such as Amyotrophic Lateral Sclerosis (ALS), by Using a HDAC Inhibiting Agent.

摘要

A method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as amyotrophic lateral sclerosis (ALS), includes administering a histone deacetylase (HDAC) inhibitor in a subject in need thereof. The HDAC inhibitor includes sodium butyrate or sodium phenylbutyrate.